Observational study / 2016
In men, higher anthocyanin intake was linked to lower nonfatal MI risk, and higher flavanone intake was linked to lower ischemic stroke risk.
Researchers followed 43,880 healthy men in the Health Professionals Follow-Up Study for 24 years to examine associations between habitual anthocyanin and flavanone intake and CVD events. Over follow-up, 4,046 MI and 1,572 stroke cases were confirmed. Higher anthocyanin intake was inversely associated with nonfatal MI (multivariate HR: 0.87; 95% CI: 0.75, 1.00; P = 0.04; P-trend = 0.098), which was stronger in normotensive participants (HR: 0.81; 95% CI: 0.69, 0.96; P-interaction = 0.03), but was not associated with total or fatal MI or stroke. Higher flavanone intake was not associated with MI or total stroke risk, but was linked to lower risk of ischemic stroke (HR: 0.78; 95% CI: 0.62, 0.97; P = 0.03, P-trend = 0.059), with the greatest magnitude in participants aged ≥65 years (P-interaction = 0.04).
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- 43,880 healthy men with no prior diagnosed CVD or cancer
- What was measured
- Myocardial infarction (MI) and stroke
THE PAPER
Habitual intake of anthocyanins and flavanones and risk of cardiovascular disease in men.
Cassidy A, Bertoia M, Chiuve S, Flint A, Forman J, Rimm EB. Am J Clin Nutr, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.